California's largest children's hospital system discontinued offering gender-affirming hormone therapy to youth under 19, a move attributed to pressures from the Trump administration, according to multiple news sources. The decision, effective February 6, 2026, reflects a broader trend of hospitals and clinics scaling back such care, impacting transgender youth and their families.
The hospital system's action follows a pattern seen across the country, as reported by NPR News. The halt in hormone treatments specifically impacts transgender youth, a vulnerable population that has relied on these treatments for their well-being. One family in San Diego, as highlighted by a multi-source report from NPR News, found significant improvement in their child's well-being through hormone treatments.
The pressures from the Trump administration were cited as a key factor in the hospital system's decision, although specific details of these pressures were not immediately available. The move has raised concerns among advocates for transgender rights, who fear it could limit access to crucial medical care for young people.
This news comes amidst other developments in the healthcare and technology sectors. While this story unfolds, other news includes an artificial-lung system that kept a patient alive for 48 hours until a transplant, as reported by Nature News. Additionally, Time magazine's "In the Loop" newsletter highlighted the potential of AI to reshape clinical trials and the pharmaceutical industry.
Discussion
AI Experts & Community
Be the first to comment